TLR9, Fc Chimera, Recombinant, Mouse, aa26-818 (Toll-like Receptor 9, CD289)
Catalog No : USB-145847
682.78€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | TLR9, Fc Chimera, Recombinant, Mouse, aa26-818 (Toll-like Receptor 9, CD289) | ||
|---|---|---|---|
| Catalog No | USB-145847 | ||
| Supplier’s Catalog No | 145847 | ||
| Supplier | US Biologicals | ||
| Source antigen | CHO cells | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~95% (SDS-PAGE under reducing conditions and visualized by silver stain). Endotoxin: ≤0.10EU/1ug (LAL) | ||
| Form | Supplied as a lyophilized powder from PBS, pH 7.2. BSA free. Reconstitute with 500ul PBS. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | ~95% (SDS-PAGE under reducing conditions and visualized by silver stain). Endotoxin: ≤0.10EU/1ug (LAL) | ||
| Description | TLR9 (Tolllike receptor 9), designated CD289, is a member of the TLR family of innate immune receptors that is mainly expressed by colonic epithelium, CD123+ plasmacytoid predendritic cells (pDC), and splenic transitional B cells. TLR9 responds to unmethylated DNA CpG motifs that occur mainly in bacteria and viruses. Mouse TLR9 cDNA encodes a 1032 amino acid (aa) type I transmembrane glycoprotein with a 793aa extracellular domain (ECD) that contains 26 leucinerich repeats (LRRs, aa 26818), and a 193aa cytoplasmic domain with a TIR sequence that dimerizes with signaling adaptors such as MyD88. The mouse TLR9 ECD shares 87% aa sequence identity with rat and 71-74% with human, feline, canine, equine, porcine, bovine and ovine TLR9. Predicted splice forms vary at the N-terminus by initiating either upstream or downstream of the standard site. The full-length 150kD form, which is ligand-binding but nonsignaling, is found in the endoplasmic reticulum. It undergoes accessory protein-mediated translocation either to the cell membrane or to lysosomes. TLR9 is cleaved to remove LRR1-14, producing an 80kD signaling fragment within acidic endolysosomes where it encounters microbial CpG DNA rather than selfDNA. However, immune complexes of self-DNA with lupus erythematosus antiDNA antibodies can induce TLR9 activation and IFN-alpha production in pDC. A soluble form also found in endosomes includes all 26 LRRs and negatively regulates active TLR9. Activation of TLR9 contributes to splenocyte proliferation, pDC maturation, macrophage inflammatory cytokine production, Th1 inflammatory responses, NK cell activation and recruitment, B cell surface MHC class II up-regulation and immunoglobulin production, and generation and maintenance of memory B cells. Description: CHO-expressed recombinant protein corresponding to mouse TLR9 (Leu26-Asp818; Accession #AAK29625), the sequence IEGRMDP, followed by mouse IgG2a (Glu98-Lys330). Structure: Disulfide-linked homodimer Molecular Mass: Predicted: 115.8kD (monomer) Observed: 140-179kD (SDS-PAGE, reducing conditions) | ||
Product Details
© 2020 Imugex All Rights Reserved